Dr. Brunner received her Ph.D. at Cambridge University (U.K.) and postdoctoral training at Columbia University (USA).
She joined PsychoGenics in 1999 where she developed preclinical tests for cognition, neurodegeneration, autism, and others. She conceived the SmartCube® system and worked in the development of PsychoGenics’ AI technologies. In the recent past she also worked in digital health, having founded Early Signal Foundation and ScienceForward LLC, organizations focused on digital technologies for human health. She has worked closely with many nonprofits working in rare disorders, including the Tuberous Sclerosis Alliance, Children’s Tumor Foundation, and International Rett Syndrome Foundation.
She enjoys photography and painting and practices the old disciplines of Kobudo and Iaijutsu.